Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

Share Price is delayed by 15 minutes
Get Live Data
0.0105    0.00 (0.00%)
Bid:
0.009
Ask:
0.012
Spread: 0.003 (33.333%)
Market Cap: £1.64m
SYN Live PriceLast checked at - London Stock Exchange

Intraday Synergia Energy Share Chart

Trading Update

13 Feb 2017 07:00

RNS Number : 6694W
Plastics Capital PLC
13 February 2017
 

 

 

 

Plastics Capital plc

(The "Company" or the "Group")

 

Trading Update

 

Plastics Capital plc (AIM: PLA), the niche plastics products group, is pleased to provide a Q3 trading update and to confirm that the Company continues to trade in line with market expectations.

 

Group Trading

Group revenues were ahead of expectations in Q3 as a result of stronger than anticipated demand. Gross profit margins remain good but a little lower than historically, due to the changing business mix resulting from the acquisition of Synpac. We have meanwhile increased investment in sales, marketing and new product development across the Group to continue to drive the growth of the business and so profits for the current financial year remain on track to meet market expectations.

 

Industrial Division

Bearings and mandrel sales were strong during Q3, supported by new business wins that entered production this financial year and growing demand from US customers. We have also had some excellent new project successes which we expect will enter production in upcoming years and which have replenished the new business pipeline. We are adding sales resources and capacity in both businesses to enable both to meet increasing demand in line with our five year targets.

 

Matrix activities continue to make progress in line with our strategy of getting "closer to the customer" and broadening the range of die-cutting and die-making consumables that we have to offer. In December we concluded an agreement with our Italian distributor enabling us to take a significant minority stake in this business which also makes a range of creasing matrix products under the brand name MITO. We have also applied for patents for a new product development being undertaken with one of our Japanese distributors, which we believe has excellent market potential and product trials are ongoing.

 

Film Division

The Films Division has had a varied year so far. Flexipol has continued to grow sales and profits, whilst Synpac has traded in line with the expectations that we had formed at the time the acquisition was concluded in July 2016. However, Palagan has experienced some weakness in trading as it made important changes to its business strategy designed to position it for longer term growth.

 

At Flexipol we have nearly concluded the installation of an additional extruder which will increase capacity by a third and is expected to enable the business to continue growing at the same rate over the next five years or so. At Synpac we are busy working on procurement and sales synergies with the other companies in the Division, and integrating it into the Group.

 

We are currently making important changes within Palagan in terms of its business strategy, which are designed to enable the business to achieve long-term growth. We are investing in the recruitment, training and development of operational staff, the introduction of new films and the development of some innovative products. We anticipate that it will take another 6 -12 months to conclude this transitional phase, at which point Palagan will be in a good position to increase sales and profitability.

 

 

Commenting, Faisal Rahmatallah, Executive Chairman, said:

 

"Trading conditions are generally good and we are busy implementing the investments we have previously highlighted as key to fulfilling the Group's five year strategy. We are very pleased with progress generally across the Group and particularly in our two most substantial business areas, plastic bearings and specialist sacks. Overall, we anticipate that performance over the second half of the financial year will enable us to announce results that are in line with market expectations."

 

 

 

Plastics Capital plc Tel: 020 7978 0574

Faisal Rahmatallah, Executive Chairman

Nick Ball, Finance Director

 

Cenkos Securities Tel: 020 7397 8900

Mark Connelly

Callum Davidson

 

Allenby Capital Tel: 020 3002 2074

Katrina Perez

David Hart

 

Walbrook PR Ltd Tel: 020 7933 8780

Paul Cornelius plasticscapital@walbrookpr.com

Helen Cresswell

 

 

Notes to Editor

Plastics Capital is a niche manufacturer of specialist plastic products. Applications for these products vary widely and examples include:

• Packaging for the food manufacturing and distribution - films, sacks and pouches

• Steering columns and instrument control knobs in the automotive industry - plastic ball bearings

• Hydraulic and industrial rubber hose manufacture - various types of plastic mandrel

• Cardboard box manufacture - plastic creasing matrices

 

Plastics Capital's business model is based on understanding customers' problems in depth, and then developing and mass producing proprietary, technical solutions for these problems.

 

The business operates through two divisions, Films and Industrial, and has the majority of its production in five UK based factories, with a further three factories in Asia. Approximately 40% of its £55 million sales are made outside the UK to more than 80 countries.

Further information can be found on www.plasticscapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSDFFIFLID
Date   Source Headline
23rd Mar 20178:37 amRNSHolding(s) in Company
27th Feb 20177:00 amRNSPresentation at ShareSoc Growth Company Seminar
20th Feb 20171:30 pmRNSDirector/PDMR Shareholding
13th Feb 20177:00 amRNSTrading Update
30th Jan 20173:45 pmRNSIssue of Equity and Directors' Shareholdings
20th Jan 201711:43 amRNSResult of Scrip Dividend Alternative
12th Jan 20177:00 amRNSGrowth & Innovation Forum
11th Jan 20172:38 pmRNSDirector/PDMR Shareholding
29th Dec 201610:15 amRNSScrip Dividend Reference Price
5th Dec 20167:00 amRNSHalf-year Report
14th Nov 20167:00 amRNSInvestor Results Briefing
9th Nov 20167:00 amRNSNotice of Results
26th Oct 201610:08 amRNSHolding(s) in Company
21st Oct 201612:32 pmRNSHolding(s) in Company
28th Sep 20167:00 amRNSTrading update
21st Sep 201612:43 pmRNSDirector/PDMR Shareholding
14th Sep 20169:25 amRNSDirector / PDMR Dealing
12th Sep 201610:46 amRNSHolding(s) in Company
6th Sep 201612:16 pmRNSIssue of Equity and Directors' Shareholdings
5th Sep 201611:53 amRNSDirector/PDMR Dealing
25th Aug 20162:51 pmRNSResult of Scrip Dividend Alternative
22nd Aug 20165:28 pmRNSDirector/PDMR Dealing
11th Aug 20167:00 amRNSScrip Dividend Reference Price
1st Aug 20167:00 amRNSScrip Dividend Alternative
29th Jul 20169:28 amRNSResult of AGM
26th Jul 20169:45 amRNSHolding(s) in Company
18th Jul 20167:00 amRNSAcquisition
14th Jul 20166:08 pmRNSDirector/PDMR Shareholding
11th Jul 201611:42 amRNSRE: AGM
11th Jul 201611:18 amRNSHolding(s) in Company
7th Jul 20167:00 amRNSAnnual Accounts & Annual General Meeting
4th Jul 201612:01 pmRNSFinal Results - Replacement
4th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSNotice of Results
3rd May 20167:00 amRNSTrading Update
28th Apr 20167:00 amRNSHolding(s) in Company
26th Apr 20167:00 amRNSUK Investor Show 2016
31st Mar 201611:48 amRNSHolding(s) in Company
4th Mar 201611:02 amRNSHolding(s) in Company
2nd Mar 201611:16 amRNSHolding(s) in Company
26th Feb 20163:52 pmRNSHolding(s) in Company
15th Feb 20167:00 amRNSTrading Update
3rd Feb 20164:49 pmRNSHolding(s) in Company
3rd Feb 20163:52 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSHolding(s) in Company
15th Dec 201510:23 amRNSHolding(s) in Company
11th Dec 20157:00 amRNSHolding(s) in Company
7th Dec 20157:00 amRNSHalf Yearly Report
13th Nov 20157:00 amRNSNotice of Results
20th Oct 20159:32 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.